ACVBP-R regimen: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a [[chemotherapy regimen]] consisting of | {{PAGENAME}} refers to a [[chemotherapy regimen]] consisting of [[doxorubicin]], [[cyclophosphamide]], [[vindesine]], [[bleomycin]], [[prednisone]], and [[rituximab]] used in the treatment of [[non-Hodgkin lymphoma]]. | ||
==Regimen== | ==Regimen== | ||
[[Doxorubicin|{{button|A – Doxorubicin (Adriamycin)}}]] | |||
[[Cyclophosphamide|{{button|C – Cyclophosphamide}}]] | [[Cyclophosphamide|{{button|C – Cyclophosphamide}}]] | ||
[[ | [[Vindesine|{{button|V – Vindesine}}]] | ||
[[ | [[Bleomycin|{{button|B – Bleomycin}}]] | ||
[[Prednisone|{{button|P – Prednisone}}]] | [[Prednisone|{{button|P – Prednisone}}]] | ||
| Line 21: | Line 23: | ||
==Indications== | ==Indications== | ||
* [[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma, untreated]]<ref name="pmid22118442">{{cite journal| author=Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O et al.| title=Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. | journal=Lancet | year= 2011 | volume= 378 | issue= 9806 | pages= 1858-67 | pmid=22118442 | doi=10.1016/S0140-6736(11)61040-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22118442 }} </ref> | |||
==See also== | ==See also== | ||
* [[ACVBP-R regimen]] | |||
* [[CDOP regimen]] | |||
* [[CHOEP regimen]] | |||
* [[CHOP regimen]] | |||
* [[CHOP Intensified regimen]] | |||
* [[CHOP Modified regimen]] | |||
* [[CNOP regimen]] | |||
* [[DA-EPOCH regimen]] | |||
* [[DA-R-EPOCH regimen]] | |||
* [[LR-CHOP-21 regimen]] | |||
* [[m-BACOD regimen]] | |||
* [[MACOP-B regimen]] | |||
* [[MCOP regimen]] | |||
* [[ProMACE-CytaBOM regimen]] | |||
* [[ProMACE-MOPP regimen]] | |||
* [[R-CDOP regimen]] | |||
* [[R-CEOP regimen]] | |||
* [[R-CHMP regimen]] | |||
* [[R-CHOEP-14 regimen]] | |||
* [[R-CHOP Intensified regimen]] | |||
* [[R-CVP regimen]] | |||
* [[R-GCVP regimen]] | |||
* [[R-HCVAD/R-MA regimen]] | |||
* [[R-miniCEOP regimen]] | |||
* [[R-miniCHOP regimen]] | |||
* [[R2CHOP regimen]] | |||
* [[VR-CHOP regimen]] | |||
==References== | ==References== | ||
Revision as of 22:50, 23 February 2015
|
WikiDoc Resources for ACVBP-R regimen |
|
Articles |
|---|
|
Most recent articles on ACVBP-R regimen Most cited articles on ACVBP-R regimen |
|
Media |
|
Powerpoint slides on ACVBP-R regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on ACVBP-R regimen at Clinical Trials.gov Trial results on ACVBP-R regimen Clinical Trials on ACVBP-R regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on ACVBP-R regimen NICE Guidance on ACVBP-R regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on ACVBP-R regimen Discussion groups on ACVBP-R regimen Patient Handouts on ACVBP-R regimen Directions to Hospitals Treating ACVBP-R regimen Risk calculators and risk factors for ACVBP-R regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for ACVBP-R regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
ACVBP-R regimen refers to a chemotherapy regimen consisting of doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone, and rituximab used in the treatment of non-Hodgkin lymphoma.
Regimen
Indications
See also
- ACVBP-R regimen
- CDOP regimen
- CHOEP regimen
- CHOP regimen
- CHOP Intensified regimen
- CHOP Modified regimen
- CNOP regimen
- DA-EPOCH regimen
- DA-R-EPOCH regimen
- LR-CHOP-21 regimen
- m-BACOD regimen
- MACOP-B regimen
- MCOP regimen
- ProMACE-CytaBOM regimen
- ProMACE-MOPP regimen
- R-CDOP regimen
- R-CEOP regimen
- R-CHMP regimen
- R-CHOEP-14 regimen
- R-CHOP Intensified regimen
- R-CVP regimen
- R-GCVP regimen
- R-HCVAD/R-MA regimen
- R-miniCEOP regimen
- R-miniCHOP regimen
- R2CHOP regimen
- VR-CHOP regimen
References
- ↑ Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O; et al. (2011). "Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial". Lancet. 378 (9806): 1858–67. doi:10.1016/S0140-6736(11)61040-4. PMID 22118442.